Literature DB >> 24709930

Genome-wide expression profiles in very low birth weight infants with neonatal sepsis.

María Cernada1, Eva Serna2, Christine Bauerl3, María Carmen Collado3, Gaspar Pérez-Martínez3, Máximo Vento4.   

Abstract

BACKGROUND: Bacterial sepsis is associated with high morbidity and mortality in preterm infants. However, diagnosis of sepsis and identification of the causative agent remains challenging. Our aim was to determine genome-wide expression profiles of very low birth weight (VLBW) infants with and without bacterial sepsis and assess differences.
METHODS: This was a prospective observational double-cohort study conducted in VLBW (<1500 g) infants with culture-positive bacterial sepsis and non-septic matched controls. Blood samples were collected as soon as clinical signs of sepsis were identified and before antibiotics were initiated. Total RNA was processed for genome-wide expression analysis using Affymetrix gene arrays.
RESULTS: During a 19-month period, 17 septic VLBW infants and 19 matched controls were enrolled. First, a three-dimensional unsupervised principal component analysis based on the entire genome (28 000 transcripts) identified 3 clusters of patients based on gene expression patterns: Gram-positive sepsis, Gram-negative sepsis, and noninfected control infants. Furthermore, these groups were confirmed by using analysis of variance, which identified a transcriptional signature of 554 of genes. These genes had a significantly different expression among the groups. Of the 554 identified genes, 66 belonged to the tumor necrosis factor and 56 to cytokine signaling. The most significantly overexpressed pathways in septic neonates related with innate immune and inflammatory responses and were validated by real-time reverse transcription polymerase chain reaction.
CONCLUSIONS: Our preliminary results suggest that genome-wide expression profiles discriminate septic from nonseptic VLBW infants early in the neonatal period. Further studies are needed to confirm these findings.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  biomarkers; genome-wide expression profile; premature infant; sepsis

Mesh:

Substances:

Year:  2014        PMID: 24709930     DOI: 10.1542/peds.2013-2552

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  27 in total

Review 1.  Diagnostics for neonatal sepsis: current approaches and future directions.

Authors:  Pui-Ying Iroh Tam; Catherine M Bendel
Journal:  Pediatr Res       Date:  2017-06-28       Impact factor: 3.756

2.  LPS Stimulation of Cord Blood Reveals a Newborn-Specific Neutrophil Transcriptomic Response and Cytokine Production.

Authors:  Brittany Mathias; Juan C Mira; Jonathan P Rehfuss; Jaimar C Rincon; Ricardo Ungaro; Dina C Nacionales; M Cecilia Lopez; Henry V Baker; Lyle L Moldawer; Shawn D Larson
Journal:  Shock       Date:  2017-05       Impact factor: 3.454

Review 3.  An Immunological Perspective on Neonatal Sepsis.

Authors:  Bernard Kan; Hamid Reza Razzaghian; Pascal M Lavoie
Journal:  Trends Mol Med       Date:  2016-03-15       Impact factor: 11.951

4.  Postnatal Age Is a Critical Determinant of the Neonatal Host Response to Sepsis.

Authors:  James L Wynn; Scott O Guthrie; Hector R Wong; Patrick Lahni; Ricardo Ungaro; M Cecilia Lopez; Henry V Baker; Lyle L Moldawer
Journal:  Mol Med       Date:  2015-06-02       Impact factor: 6.354

Review 5.  Adverse consequences of neonatal antibiotic exposure.

Authors:  Charles M Cotten
Journal:  Curr Opin Pediatr       Date:  2016-04       Impact factor: 2.856

6.  Validation of the Sepsis MetaScore for Diagnosis of Neonatal Sepsis.

Authors:  Timothy E Sweeney; James L Wynn; María Cernada; Eva Serna; Hector R Wong; Henry V Baker; Máximo Vento; Purvesh Khatri
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-15       Impact factor: 3.164

7.  Transcriptome profiles discriminate between Gram-positive and Gram-negative sepsis in preterm neonates.

Authors:  María Cernada; Alejandro Pinilla-González; Julia Kuligowski; José Manuel Morales; Sheila Lorente-Pozo; José David Piñeiro-Ramos; Anna Parra-Llorca; Inmaculada Lara-Cantón; Máximo Vento; Eva Serna
Journal:  Pediatr Res       Date:  2021-03-25       Impact factor: 3.756

8.  DNA Methylation Analysis to Unravel Altered Genetic Pathways Underlying Early Onset and Late Onset Neonatal Sepsis. A Pilot Study.

Authors:  Sheila Lorente-Pozo; Paula Navarrete; María José Garzón; Inmaculada Lara-Cantón; Jesús Beltrán-García; Rebeca Osca-Verdegal; Salvador Mena-Mollá; Eva García-López; Máximo Vento; Federico V Pallardó; José Luis García-Giménez
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

9.  Whole Blood Gene Expression Reveals Specific Transcriptome Changes in Neonatal Encephalopathy.

Authors:  Paolo Montaldo; Myrsini Kaforou; Gabriele Pollara; David Hervás-Marín; Ines Calabria; Joaquin Panadero; Laia Pedrola; Peter J Lally; Vânia Oliveira; Anup Kage; Gaurav Atreja; Josephine Mendoza; Aung Soe; Santosh Pattnayak; Seetha Shankaran; Máximo Vento; Jethro Herberg; Sudhin Thayyil
Journal:  Neonatology       Date:  2018-10-10       Impact factor: 4.035

10.  Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial.

Authors:  Nancy A Rodriguez; Maximo Vento; Erika C Claud; Chihsiung E Wang; Michael S Caplan
Journal:  Trials       Date:  2015-10-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.